ライフサイエンスコーパス: epilepsy surgery

1 e damage to eloquent cortex during resective epilepsy surgery.

2 imaging, often have a favorable outcome with epilepsy surgery.

3 n be used to delineate the resection area in epilepsy surgery.

4 sive monitoring with subdural electrodes for epilepsy surgery.

5 recordings from patients being evaluated for epilepsy surgery.

6 ntracranial electrodes during evaluation for epilepsy surgery.

7 rodes were implanted for assessment prior to epilepsy surgery.

8 lobe epilepsy obtained during evaluation for epilepsy surgery.

9 will invariably be the case in those having epilepsy surgery.

10 oral lobe origin who were seizure-free after epilepsy surgery.

11 recordings from patients who have undergone epilepsy surgery.

12 standing brain recovery mechanisms following epilepsy surgery.

13 as others emphasise the numerous barriers to epilepsy surgery.

14 antitative prognoses for patients undergoing epilepsy surgery.

15 n patients who have been judged eligible for epilepsy surgery.

16 electroencephalographic analyses made before epilepsy surgery.

17 tex, selected from 13 patients who underwent epilepsy surgery.

18 change in IQ (delta IQ) following pediatric epilepsy surgery.

19 low perioperative mortality (0.1%-0.5%) from epilepsy surgery.

20 vity intraoperatively in patients undergoing epilepsy surgery.

21 they are not considered good candidates for epilepsy surgery.

22 otypes, ultimately refining the prognosis of epilepsy surgery.

23 nts with temporal lobe epilepsy submitted to epilepsy surgery.

24 mor brain (NT) control samples obtained from epilepsy surgery.

25 not deter from exploring the possibility of epilepsy surgery.

26 Nonlesional extratemporal lobe epilepsy surgery.

27 were likely to have excellent outcomes after epilepsy surgery.

28 ctable-seizure patients being considered for epilepsy surgery.

29 electroencephalographic (EEG) monitoring and epilepsy surgery.

30 8%) had an excellent outcome after resective epilepsy surgery.

31 (MRI) is a favorable prognostic finding for epilepsy surgery.

32 fractory to treatment and not candidates for epilepsy surgery.

33 the seizure disorder to pharmacotherapy and epilepsy surgery.

34 identify seizure-onset zones for subsequent epilepsy surgery.

35 pediatric patients undergoing evaluation for epilepsy surgery.

36 in the neocortex of four patients undergoing epilepsy surgery.

37 predicting the long-term seizure outcome of epilepsy surgery.

38 rtion of patients who undergo evaluation for epilepsy surgery.

39 rse seizure control with pharmacotherapy and epilepsy surgery.

40 analysed in 10 children being evaluated for epilepsy surgery.

41 nter study, 396 patients underwent resective epilepsy surgery.

42 atients (mean age, 12.2 years) evaluated for epilepsy surgery, 28 of whom had magnetic resonance imag

43 25 males, 28 females) who were evaluated for epilepsy surgery: 42 underwent unilateral temporal lobe

44 e German Neuropathology Reference Center for Epilepsy Surgery (59%).

45 making in some patients being evaluated for epilepsy surgery and help to explain the biological basi

46 ature and causes of the presumed underuse of epilepsy surgery and the elaboration of strategies to ad

47 All 23 patients were candidates for epilepsy surgery and underwent both IAP and resting-stat

48 e is high-level evidence for the efficacy of epilepsy surgery and use of newer antiepileptic drugs fo

49 e most common lesion in patients who require epilepsy surgery, and approximately 50% of patients with

50 options included antiepileptic drug changes, epilepsy surgery, and pacemaker implantation.

51 udy discusses the challenges of MRI-negative epilepsy surgery, and the strategies in using advanced M

52 gs who underwent (nonlesional) extratemporal epilepsy surgery are confined to a highly select group o

53 zure outcome of 693 adults who had resective epilepsy surgery between 1990 and 2010 and used survival

54 Three hundred ninety-three patients who had epilepsy surgery between January 1986 and January 1996 w

55 ity of life (HRQOL) improves after resective epilepsy surgery, but data are limited to short follow-u

56 rdings in patients undergoing assessment for epilepsy surgery, but we do not know their potential for

57 Resective epilepsy surgery can be beneficial, particularly for pat

58 Epilepsy surgery can be offered in a highly selected sub

59 Epilepsy surgery can lead to seizure freedom in patients

60 Of 298 consecutive epilepsy surgery candidates (between 2001 and 2006), 160

61 a Wada test in the presurgical evaluation of epilepsy surgery candidates in the light of research on

62 s part of a prospective observation study of epilepsy surgery candidates not sufficiently localized w

63 This work was part of a cohort study of epilepsy surgery candidates not sufficiently localized w

64 ion with a high positive predictive value in epilepsy surgery candidates who typically require ICEEG.

65 predicting seizure-free surgical outcome in epilepsy surgery candidates who typically require ICEEG.

66 urce imaging (MSI) and ICEEG localization in epilepsy surgery candidates.

67 lateralize and localize language function in epilepsy surgery candidates.

68 r these functions, thus reducing the risk of epilepsy surgery causing new morbidities.

69 llel-group clinical trial performed at 16 US epilepsy surgery centers.

70 rt operated on over a similar period in four epilepsy surgery centres, in Brazil, France, Italy, and

71 evaluation and review at a multidisciplinary epilepsy surgery conference, some of these patients were

72 From our epilepsy surgery database of 1988 to 1996, we selected a

73 32% of patients who were offered epilepsy surgery decided against proceeding.

74 The success or failure of an epilepsy surgery depends greatly on the localization of

75 Evaluation for epilepsy surgery disclosed two independent epileptic foc

76 s has a specific application in the field of epilepsy surgery (electroencephalographic-correlated fun

77 Because epilepsy surgery eliminates seizures in some people, we

78 alized tonic-clonic seizures obtained during epilepsy surgery evaluation in 53 patients.

79 to the literature of its use in MRI-negative epilepsy surgery evaluation, which up to now remains som

80 emission computed tomography in MRI-negative epilepsy surgery evaluation.

81 ven a whole hemisphere may be candidates for epilepsy surgery even when, due to microscopic malformat

82 n specimens from 9523 patients who underwent epilepsy surgery for drug-resistant seizures in 36 cente

83 ure outcome of patients undergoing resective epilepsy surgery for this condition.

84 tients, who had undergone a second resective epilepsy surgery from 1989 to 2009.

85 Individuals with auras only after epilepsy surgery had a higher COSY than those who were s

86 th drug-resistant epilepsy who had undergone epilepsy surgery had a significantly higher rate of free

87 tes, the short-term and long-term success of epilepsy surgery has not changed substantially in recent

88 cale microarray studies on brain tissue from epilepsy surgery have been published over the last 10 ye

89 Recent advances in epilepsy surgery have developed a resurgence of interest

90 hic (ECoG) recordings in patients undergoing epilepsy surgery have shown that functional activation i

91 trospectively, to the benefits of successful epilepsy surgery in a cohort of 105 patients.

92 this study to identify long-term outcome of epilepsy surgery in adults by establishing patterns of s

93 patient specific computational modelling of epilepsy surgery in order to inform treatment strategies

94 Achieving complete seizure control with epilepsy surgery in refractory patients reduces the risk

95 atment appears to be higher than the risk of epilepsy surgery in suitable candidates.

96 ead at onset, making them poorly amenable to epilepsy surgery in the absence of associated focal brai

97 Our data support the early consideration of epilepsy surgery in this patient group.

98 , than the 'Life-satisfaction' scale and the Epilepsy Surgery Inventory 55 (ESI-55) scales.

99 Our study also indicates that epilepsy surgery is a valuable alternative in the treatm

100 Epilepsy surgery is an effective treatment for refractor

101 Epilepsy surgery is indicated for patients with focal se

102 tween MRI and EEG data, a good outcome after epilepsy surgery is possible if EEG ictal onsets are def

103 s achieving long-term freedom from seizures, epilepsy surgery is still done in a small subset of drug

104 A priority for the development of epilepsy surgery is the generation of high-level evidenc

105 Epilepsy surgery is the most effective way to control se

106 One challenge in dominant temporal lobe epilepsy surgery is to remove sufficient epileptogenic t

107 Reoperation after failed resective epilepsy surgery led to approximately 70% long-time seiz

108 surgical psychiatric comorbidities following epilepsy surgery may be another expression of this compl

109 loring of resections for children undergoing epilepsy surgery may enhance long-term memory outcome.

110 or carefully selected individuals, resective epilepsy surgery may offer the best hope for a cure.

111 bMed literature search, using the key words 'Epilepsy Surgery', 'Neuromodulation', 'Neuroablation', '

112 Few epilepsy surgery outcome data are available from series

113 aded on the The International League against Epilepsy surgery outcome scale.

114 studies show a stagnant or declining rate of epilepsy surgery over time, despite the evidence and gui

115 In paediatric epilepsy surgery patients with hemimegalencephaly (HME;

116 METHOD: We calculated COSY in 819 epilepsy surgery patients with up to 25 years follow-up.

117 sing microwire electrodes implanted in human epilepsy surgery patients.

118 iminates seizures in some people, we used an epilepsy surgery population to examine how seizure contr

119 nset zone are essential to make MRI-negative epilepsy surgery possible and worthwhile for the patient

120 ntially the extent of cortical resections in epilepsy surgery procedures without compromising seizure

121 ficant shift in the role of the Wada test in epilepsy surgery programmes.

122 Epilepsy surgery reduced seizure activity in randomized

123 There is an argument that epilepsy surgery remains underused, but the evidence to

124 se comprising 16 patients who have undergone epilepsy surgery, revealing rich-club structures within

125 rbid depression and the first 6 months after epilepsy surgery seem to be particular risk factors.

126 lerosis, and the systematic investigation of epilepsy surgery specimens in general.

127 the clinic population, and to outcome after epilepsy surgery, than the 'Life-satisfaction' scale and

128 ography (ECoG) is routinely performed during epilepsy surgery there is little evidence that the exten

129 k/benefit ratio and of realistic outcomes of epilepsy surgery; this may help reduce the number of pat

130 Epilepsy surgery was less effective when there were extr

131 The frequency of seizure-free outcome after epilepsy surgery was similar for infants, children, and

132 diagnostic modalities remains suboptimal in epilepsy surgery, we evaluated whether interictal spike

133 we probed specimens (n = 10) resected during epilepsy surgery with a panel of 13 antibodies recognizi

134 Thus, 100 patients who underwent two-stage epilepsy surgery with chronic electrocorticography recor

135 nterictal (18)F-FDG PET, followed by 2-stage epilepsy surgery with chronic subdural electrocorticogra

136 FRs can thus be used for tailoring epilepsy surgery with repeated intraoperative ECoG measu

137 All patients underwent epilepsy surgery, with the operations based on ictal EEG

138 e epilepsy is the most common indication for epilepsy surgery, yet little is known about its 'natural